Tag - johnson-johnson

 
Menu
Search
 
November 25, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

JOHNSON JOHNSON

Japan Times
BUSINESS
Aug 12, 2022
Johnson & Johnson to end global sales of talc-based baby powder
The company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen.
Japan Times
BUSINESS
Mar 15, 2022
Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia's invasion of Ukraine and the needs of sick patients.
Japan Times
JAPAN
Feb 24, 2022
Japan to accept Johnson & Johnson COVID vaccine for border entry next month
The J&J shot, which has not been approved in Japan, will join a list of three other shots that have been approved by regulators as sufficient for nonresidents to enter.
Japan Times
WORLD / FOCUS
Feb 5, 2022
Inside Johnson & Johnson’s secret plan to cap litigation payouts to cancer victims
If J&J succeeds, some experts argue, it could provide a blueprint for corporate America on how to circumvent jury trials involving allegations of defective products or misconduct.
Japan Times
BUSINESS / FOCUS
Nov 16, 2021
Breakups usher in a new era of corporate conglomerates
Activists and corporate governance advocates cheered splits by GE, J&J and Toshiba, but tech firms have been driving unrelated transactions, creating what are called 'neoconglomerates.”
Japan Times
WORLD
Aug 7, 2021
South African study shows high protection from Johnson & Johnson shot
The country's health regulator approved the J&J shot in April, and it is being used in the national vaccine program alongside Pfizer's.
Japan Times
WORLD
Apr 24, 2021
U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately
Officials found just 15 cases among the 8 million shots given that had experienced the syndrome involving severe blood clots and low platelets as a result of the vaccine.
Japan Times
WORLD / Science & Health
Apr 17, 2021
Why the vaccine safety numbers are still fuzzy
If there is a connection between the Johnson & Johnson vaccine and a rare clotting syndrome, new cases are likely to emerge now that the word is out.
Japan Times
COMMENTARY / World
Apr 14, 2021
The FDA’s caution on the J&J vaccine is a costly mistake
The FDA acted after blood clots were observed in less than one in a million people who have received the J&J vaccine. COVID-19 has already killed 1,712 out of every million Americans.
Japan Times
WORLD / Science & Health
Apr 14, 2021
Vaccine blood-clot side effect puts focus on immune reaction
Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.
Japan Times
WORLD
Apr 13, 2021
U.S. calls for pause on Johnson & Johnson vaccine after clotting cases
The concerns about the shot mirror those about AstraZeneca's, which European regulators began investigating last month after some recipients developed blood clots.
Japan Times
WORLD
Feb 28, 2021
U.S. authorizes Johnson & Johnson's COVID-19 vaccine
J&J's vaccine is expected to be used widely around the globe because it can be shipped and stored at normal refrigerator temperatures, making distribution easier.
Japan Times
WORLD / Science & Health
Sep 24, 2020
Johnson & Johnson’s vaccine advances, sparking optimism in race
The company's vaccine could require just one shot instead of two — important considering that the entire population of the world needs vaccination.
Japan Times
BUSINESS / Companies
Jul 17, 2020
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Japan Times
BUSINESS / Companies
Mar 31, 2020
Firms sign deals with U.S. to prep for mass-producing virus vaccines
The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available.
Japan Times
BUSINESS
Jan 28, 2020
J&J CEO says he didn't read internal documents on possible asbestos in Baby Powder
Johnson & Johnson Chief Executive Alex Gorsky told a jury Monday that he did not read all the internal company documents related to potential asbestos contamination in Johnson's Baby Powder.
Japan Times
WORLD / Science & Health
Jan 8, 2020
Largest study yet offers no clear talc link to ovarian cancer
U.S. researchers who conducted the largest study yet into whether applying powder to the genitals increases a woman's risk of ovarian cancer were unable to definitively put to rest the issue that has prompted thousands of lawsuits against Johnson & Johnson and other companies.
Japan Times
WORLD / Science & Health
Aug 27, 2019
U.S. opioid ruling gives 'green light' for other lawsuits
While some Johnson & Johnson investors were relieved that the company's $572 million penalty for fueling Oklahoma's opioid epidemic wasn't as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee.
Taiwan stuns Samurai Japan to capture Premier12 title
Japan starter Shosei Togo reacts after allowing a three-run home run against Taiwan in the fifth inning of the Premier12 final on Sunday.
Woman dies after train collides with car in Tochigi
A Moka Railway train car
Japan beats Taiwan ahead of rematch in Premier12 final
Keita Sano celebrates with his teammates after scoring on Kotaro Kiyomiya's two-run triple against Taiwan during their Premier12 game at Tokyo Dome on Saturday.
Tokyo’s newest three-star chef wants ‘harmony across every detail’
British-born Daniel Calvert earned his third Michelin star last month — a stunning achievement considering his restaurant, Sezanne, has only been open for just over three years.
'Kohaku' still matters for J-pop bragging rights
Emerging Gen Z J-pop group ME:I will perform on this year's "Kohaku Uta Gassen," national broadcaster NHK’s New Year's Eve spectacle.
Tokyo’s newest three-star chef wants ‘harmony across every detail’
British-born Daniel Calvert earned his third Michelin star last month — a stunning achievement considering his restaurant, Sezanne, has only been open for just over three years.
133-year-old Kyushu railway station remains to be partially preserved
The remains of the original Moji Station in Kitakyushu
After Shohei Ohtani bump, Iwate ironware maker sees brighter future
Kaito Kikuchi's decision to send superstar Shohei Ohtani one of his company's traditional ironware tea kettles has paid off with a surge of interest from general consumers.
Shohei Ohtani wins National League MVP award
Shohei Ohtani celebrates after hitting a three-run home run against the Padres during the National League Division Series at Dodger Stadium in Los Angeles last month.
The slow-burn success of ‘A Samurai in Time’
A 19th-century warrior gets struck by lightning and wakes to find himself in 21st-century Kyoto in Junichi Yasuda’s surprise hit “A Samurai in Time.”

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

Azabudai Hills, Tokyo’s green new downtown ‘village’
Azabudai Hills, Tokyo’s green new downtown ‘village’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER